FLEX Vascular Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
FLEX Vascular General Information
Description
Developer of endovascular devices designed to treat stenoses in arteriovenous fistulas and grafts and in peripheral vascular disease. The company offers devices that create controlled micro-incisions of any length in complex lesions of varying morphology to modify plaque and stenosis, providing acute luminal gain, improved vessel compliance, and consistent revascularization outcomes, enabling healthcare providers to prepare vessels in a simple, quick, and cost-effective way.
Contact Information
Website
www.flexvascular.comCorporate Office
- 2800 Campus Drive
- Suite 50
- Plymouth, MN 55441
- United States
Corporate Office
- 2800 Campus Drive
- Suite 50
- Plymouth, MN 55441
- United States
FLEX Vascular Timeline
FLEX Vascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 17-Apr-2026 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 29-Oct-2025 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 11-Jul-2017 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 11-Dec-2014 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 24-Nov-2014 | $1M | $3M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Oct-2012 | $2M | $2M | Completed | Generating Revenue |
FLEX Vascular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | ||||||||
| Series C | ||||||||
| Series B | 62,329 | $0.000100 | $3.3 | $206.24 | $206.24 | 1x | $9.03 | 21.36% |
| Series A | 7,065 | $0.000100 | $4.19 | $262.06 | $262.06 | 1x | $9.03 | 3.08% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
FLEX Vascular Comparisons
Industry
Financing
Details
FLEX Vascular Competitors (11)
One of FLEX Vascular’s 11 competitors is Elixir Medical, a Venture Capital-Backed company based in Milpitas, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Elixir Medical | Venture Capital-Backed | Milpitas, CA | ||||
| Arsenal Medical | Venture Capital-Backed | Waltham, MA | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
| Wallaby Medical | Venture Capital-Backed | Shanghai, China | ||||
| ShockWave Medical | Formerly VC-backed | Santa Clara, CA |
FLEX Vascular Patents
FLEX Vascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260130688-A1 | Intravascular catheter having an dual, offset expandable incising portion, related systems and methods | Pending | 12-Aug-2022 | ||
| AU-2023214268-A1 | Intravascular catheter having an expandable incising portion and embolic protection device | Active | 12-Aug-2022 | ||
| AU-2023214268-B2 | Intravascular catheter having an expandable incising portion and embolic protection device | Active | 12-Aug-2022 | ||
| EP-4321113-A1 | Intravascular catheter having an expandable incising portion and embolic protection device | Active | 12-Aug-2022 | ||
| EP-4321113-B1 | Intravascular catheter having an expandable incising portion and embolic protection device | Active | 12-Aug-2022 | A61B17/22031 |
FLEX Vascular Signals
FLEX Vascular Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| S3 Ventures | Venture Capital | Minority | ||
| Endeavour Vision | Venture Capital | Minority | ||
| RiverVest Venture Partners | Venture Capital | Minority |
FLEX Vascular FAQs
-
When was FLEX Vascular founded?
FLEX Vascular was founded in 2012.
-
Where is FLEX Vascular headquartered?
FLEX Vascular is headquartered in Plymouth, MN.
-
What is the size of FLEX Vascular?
FLEX Vascular has 23 total employees.
-
What industry is FLEX Vascular in?
FLEX Vascular’s primary industry is Surgical Devices.
-
Is FLEX Vascular a private or public company?
FLEX Vascular is a Private company.
-
What is FLEX Vascular’s current revenue?
The current revenue for FLEX Vascular is .
-
How much funding has FLEX Vascular raised over time?
FLEX Vascular has raised $72M.
-
Who are FLEX Vascular’s investors?
S3 Ventures, Endeavour Vision, and RiverVest Venture Partners have invested in FLEX Vascular.
-
Who are FLEX Vascular’s competitors?
Elixir Medical, Arsenal Medical, Spine Wave, Wallaby Medical, and ShockWave Medical are some of the 11 competitors of FLEX Vascular.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process